Shanghai Unicar-therapy Bio-medicine Technology Co.,ltd

This early-stage study is testing an experimental treatment called CD30-targeted CAR-T cell therapy for people with lymphoma that has returned or not responded to standard treatments. Researchers will collect immune cells from participants, genetically modify them to better attac…

This early-phase study is testing a new version of CAR-T cell therapy called U01 (ssCART-19) in adults and children (ages 2-75) with B-cell lymphoma that has returned or not responded to standard treatments. Doctors will collect a patient's own immune cells, modify them in a lab …